CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis

CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV

(2010) S. Miura et al.   JOURNAL OF VIROLOGY

Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide

(2010) Michael Nowak et al.   PLoS One

Regulation of Secondary Antigen-Specific CD8+ T-Cell Responses by Natural Killer T Cells

(2009) C. Hong et al.   CANCER RESEARCH

The Contrasting Roles of NKT Cells in Tumor Immunity

(2009) Jay Berzofsky et al.   CURRENT MOLECULAR MEDICINE

Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges

(2009) Madhav et al.   Frontiers in Bioscience-Landmark

CD1d Activation and Blockade: A New Antitumor Strategy

(2009) M. W. L. Teng et al.   JOURNAL OF IMMUNOLOGY

CD1d-Based Combination Therapy Eradicates Established Tumors in Mice

(2009) M. W. L. Teng et al.   JOURNAL OF IMMUNOLOGY

Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma

(2008) G. J. Renukaradhya et al.   BLOOD

Immunosuppressive mechanisms in human tumors: Why we still cannot cure cancer

(2007) Stefanie Gross et al.   IMMUNOLOGY LETTERS

Methods for detection, isolation and culture of mouse and human invariant NKT cells

(2007) Hiroshi Watarai et al.   Nature Protocols